Board Of Directors

XIFIN's Board of Directors consists of a broad set of experiences ranging from laboratory management to financial operations and business strategy, with a proven track record of guiding, successful, high-growth companies.

Page header graphic
Follow Us
XIFIN's Board of Directors consists of a broad set of experiences ranging from laboratory management to financial operations and business strategy, with a proven track record of guiding, successful, high-growth companies.

Lâle White

Executive Chairman and CEO

Lâle White is a nationally recognized expert in the field of medical financial management and regulatory compliance, with over 25 years of experience in information systems development and medical billing. She lectures extensively on these topics and has consulted for major laboratories and laboratory associations throughout the U.S. She worked with HCFA and the U.S. Office of the Inspector General to develop the first OIG Model Compliance Program. Ms. White was previously Vice President - Finance of Laboratory Corporation of America (NYSE: LH), one of the largest clinical reference laboratories in the U.S., and its predecessor National Health Laboratories (NYSE: NHLI), where she led the software development of several accounts receivable, inventory, cost accounting and financial management systems for the laboratory industry. Ms. White has a B.A in finance and an M.B.A. from Florida International University.

Peter Roshko

General Partner, Boulder Ventures

Mr. Roshko, a General Partner, has over 23 years of venture capital and investment expertise. Mr. Roshko was a General Partner at Mohr, Davidow Ventures (MDV) in Menlo Park, California for 9 years where he concentrated in software, medical devices and services. He was a Board member of Vantive Corporation for 9 years from it's founding through its IPO and subsequent sale to PeopleSoft (NASDAQ: PSFT). Additionally, Mr. Roshko is currently a Board member of Trust Company of America, Xifin, Rally Software, ProStor Systems, DatAvail and Lijit.

Judd Jessup

Judd Jessup brings over 30 years experience in managing and building successful healthcare companies. While CEO of US Labs he grew revenues to $75 MM before successfully negotiating its sale to Laboratory Corporation of America (LabCorp) in 2005. Prior to that, Judd was President of the HMO Division of FHP International, which provided healthcare to more than 1.8 million members in 11 states. He joined FHP in 1994, when FHP acquired TakeCare Inc., an HMO operating in California, Colorado, Illinois and Ohio, where Judd had been President since 1987. Judd is credited with TakeCare's growth from a 150,000 member privately held HMO in Northern California to a multi-state, publicly traded organization with 790,000 members and $1.1 billion in annual revenue. Currently, Judd serves on the Board of Directors for Corvel Corporation, a publicly held workers compensation utilization management company and NovaMed Holdings, Inc., a publicly held eye-care services provider. Judd earned his BA degree from Knox College in Illinois and his MBA from the University of Denver.

M. David Titus

Managing Partner, Windward Ventures

David Titus is co-founder and Managing Director of Windward Ventures. In addition to directing the overall development of the firm, he is responsible for a number of investments in the software field. Mr. Titus has been a director of over 25 companies, including two public companies. He is currently a director of several private companies, including Akonix Systems, Streamload and Syntricity. He is also a member of the Executive Committee for the CONNECT program in San Diego and a member of the Venture Capital Advisory Board of the San Diego Venture Group. Mr. Titus was formerly an officer of the Western Association of Venture Capitalists. Prior to founding Windward Ventures, Mr. Titus was a General Partner and Managing Director of Corporate Finance for Technology Funding, a $250 million venture capital firm, where he was responsible for directing all new investment activity from 1988 through 1992. Mr. Titus was also a co-founder and Senior Vice President of Silicon Valley Bank, a highly successful bank with headquarters in Santa Clara, California. Mr. Titus has a BA from University of California, Santa Barbara.

Carl Eibl

Managing Director, Enterprise Partners
Carl Eibl is a Managing Director at Enterprise Partners, where he both serves as an investment partner and manages the firm. Mr. Eibl serves on numerous public and private boards including Enviance, IdenTrust, NEXX Systems, NP Photonics, Pivotal Systems, and ReliOn. He also serves on the boards of CONNECT and The Sanford Burnham Institute for Medical Research. Prior to joining Enterprise in 2003, Mr. Eibl was the CEO of several high profile technology and life science companies in San Diego, including publicly-held Maxwell Technologies (MXWL). Before joining Maxwell, Mr. Eibl served as President of Stratagene Corporation (STGN), then a privately-held biotechnology company that was subsequently acquired by Agilent Corporation for $250 million. Mr. Eibl also served as CEO for Mycogen Corporation, which was sold to The Dow Chemical Company for $1.1 billion. Mr. Eibl holds a J.D. from the Boston University School of Law in Boston, MA, and a B.A. from Cornell University in Ithaca, NY.

 

Interested In Learning More? Contact us to learn how XIFIN can help your business. Call us at (858) 436-2995 or click here to complete a brief information request form.